Dr. James Chiming Kao, MD

Dr. Kao practices at Valley Digestive Health Center in Arcadia, California.

Dr. Kao's NPI, 1760645121, was assigned on July 7, 2008. Dr. Kao graduated from Duke University School Of Medicine in 2003. Dr. Kao holds California license A113337.

Dr. Kao's primary practice is Valley Digestive Health Center, at 488 Santa Clara Street, Suite 102, Arcadia, CA 91006. The practice phone is (626) 359-9555.

Dr. Kao's primary practice is Valley Digestive Health Center in Arcadia, California. Dr. Kao is also affiliated with USC Arcadia Hospital. The medical group on file is Unio Specialty Care, Urology, Encinitas (formerly Genesis Healthcare Partners). Dmand AI also links Dr. Kao to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kao practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kao's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Kao is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Kao's licenses on file in 2 states: California and New Jersey.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, colonoscopy, gastroduodenitis, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Kao treats.

CMS data shows 734 Medicare services from Dr. Kao across 11 procedure codes in 2024, for 217 Medicare patients. Medicare paid $52,566 for them.

CMS counts 217 Medicare patients who saw Dr. Kao in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kao's median patient age at 61, with 53% women.

In 2024, Dr. Kao wrote 721 Medicare Part D claims for 205 patients. 87% of them were for generic drugs. CMS names the drug for 593 of them, across 10 drugs with 11 or more claims each, at $101,653 in total drug cost. In 2023, CMS named 344 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kao for performance year 2024, reported as part of a group. Dr. Kao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kao as offering telehealth. CMS counts 116 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kao, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Kao in 2003. Dr. Kao's most frequent co-author is Terry Scott Peery, DO.

Dmand AI links Dr. Kao to 2 clinical trials. Conditions studied include Colitis, Ulcerative and Colitis. Eli Lilly and Company sponsors the most, 2.

CMS Open Payments shows 455 general payments to Dr. Kao from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $3,149.

Dr. Kao graduated from Duke University School Of Medicine in 2003.

Dr. Kao is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.